Search research articles
Contact Us
Filters
Showing results (1-10 of 321) with videos related to
Page
of 33
Sort By:
Gastroenterology Clinics of North America
|
February 22, 2011
Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies
Eamonn M M Quigley
Gastroenterology
|
July 20, 2010
Enteric dysmotility: validating the Wingate/Bangkok classification
Eamonn M M Quigley
Current Opinion in Gastroenterology
|
October 22, 2019
Editorial: Colon updates 2020 - some old, some new but novel insights throughout
Eamonn M M Quigley
Gastroenterology & Hepatology
|
December 13, 2018
Highlights of the Updated Evidence-Based IBS Treatment Monograph
Eamonn M M Quigley
Alimentary Pharmacology & Therapeutics
|
October 22, 2022
Editorial: 5-aminosalicylic acid fails to impact on irritable bowel syndrome-wrong population, intervention, target or hypothesis?
Eamonn M M Quigley
Nature Reviews. Gastroenterology & Hepatology
|
June 20, 2019
Symptoms and the small intestinal microbiome - the unknown explored
Eamonn M M Quigley
World Journal of Gastroenterology
|
January 28, 2006
Changing face of irritable bowel syndrome
Eamonn M M Quigley
Gastroenterology Clinics of North America
|
October 24, 2007
Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics
Eamonn M M Quigley
Current Gastroenterology Reports
|
November 10, 2007
Probiotics in the management of colonic disorders
Eamonn M M Quigley
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 11, 2008
Impact of bloating and distention in irritable bowel syndrome: have we wandered too far from the Manning creed?
Eamonn M M Quigley
Page
of 33
Search research articles
Search
Showing results (1-10 of 321) with videos related to
Sort By:
Page
of 33
Gastroenterology Clinics of North America
|
February 22, 2011
Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies
Eamonn M M Quigley
Gastroenterology
|
July 20, 2010
Enteric dysmotility: validating the Wingate/Bangkok classification
Eamonn M M Quigley
Current Opinion in Gastroenterology
|
October 22, 2019
Editorial: Colon updates 2020 - some old, some new but novel insights throughout
Eamonn M M Quigley
Gastroenterology & Hepatology
|
December 13, 2018
Highlights of the Updated Evidence-Based IBS Treatment Monograph
Eamonn M M Quigley
Alimentary Pharmacology & Therapeutics
|
October 22, 2022
Editorial: 5-aminosalicylic acid fails to impact on irritable bowel syndrome-wrong population, intervention, target or hypothesis?
Eamonn M M Quigley
Nature Reviews. Gastroenterology & Hepatology
|
June 20, 2019
Symptoms and the small intestinal microbiome - the unknown explored
Eamonn M M Quigley
World Journal of Gastroenterology
|
January 28, 2006
Changing face of irritable bowel syndrome
Eamonn M M Quigley
Gastroenterology Clinics of North America
|
October 24, 2007
Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics
Eamonn M M Quigley
Current Gastroenterology Reports
|
November 10, 2007
Probiotics in the management of colonic disorders
Eamonn M M Quigley
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 11, 2008
Impact of bloating and distention in irritable bowel syndrome: have we wandered too far from the Manning creed?
Eamonn M M Quigley
Page
of 33